Recombinant SARS-CoV-2 Omicron B.1.1.529 variant spike RBD protein, Biotinylated
| Size | 10 µg |
| Estimated Lead Time | 2-3 business days |
| Species | SARS-CoV-2 |
| Specificity | SARS-CoV-2 Omicron Variant B.1.1.529 |
| Accession Number | QHD43416 |
| Gene Symbols | S |
| Protein Name / Synonyms | Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) |
| Expressed Region | Arg319-Phe541. Omicron 15 mutant sites (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H) |
| Expression System | HEK293 cells |
| Conjugation | Biotin |
| Tag | C-terminal his-tag. The primary amino groups (-NH2) at the N-terminus and the side chains of lysine (K) residues were biotin-conjugated using the standard chemical labeling method. |
| Purity | >90% |
| Purity Determined By | SDS-PAGE under reducing conditions and visualized by Coomassie blue staining |
| Molecular Weight (kDa) | Recombinant protein product has a calculated molecular mass of ∼25 kDa. Due to the abundant glycosylation, it migrates as approximately ∼30 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. After deglycosylation under native and denature conditions, the protein presented as one reduced ∼25 kDa band. |
| Format | Liquid |
| Formulation | Supplied as a 0.2 µm filtered solution in PBS (pH 7.4) |
| Concentration (lot specific) | Lot specific (see the label on the vial), determined by BCA protein assay |
| Endotoxin Level | < 0.5 EU per µg of the protein as determined by the LAL method |
| Research Area | Infectious Disease, COVID-19 |
| Protein Type | Recombinant Protein |
| Shipping Type | Blue ice |
| Storage | -20°C |
Your cart is empty.
Recombinant SARS-CoV-2 Omicron B.1.1.529 variant spike RBD protein, Biotinylated
